DUBLIN--(BUSINESS WIRE)--The "Global Wearable Cardioverter Defibrillator Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering.
The value of global wearable cardioverter defibrillator market is expected to reach around USD 1100 million by 2028, by registering a CAGR of 25.45% across the globe during the forecast period, i.e. 2021-2028.
Wearable cardioverter defibrillators are wearable devices which are capable of administering electrical shock to the heart for preventing sudden cardiac death (SDC). The major cause of death is cardiovascular disorder, as a result of which, a significant number of new manufacturers are interested to invest in new technologies for providing advanced screening and treatment options. An external defibrillator is attached in the wearable cardioverter defibrillator to a vest that is worn by the patient. It is highly used in patients to bridge the situation where the patient is looking for an Implantable Cardioverter Defibrillator (ICD).
The increasing investment in various international healthcare programs funded by the government and other organizations such as the World Health Organization, increasing old age population, changes in disease prevalence or incidence rate, and increasing cost of services, are the major factors accelerating the market growth.
The global wearable cardioverter defibrillator market consists of various segments that are segmented by indication, demography, end user, and by region. The market is further segmented by demography into pediatric, adults, and geriatric. Out of these, the adult segment recorded the highest share, as the adult population in the world has increased rapidly over the past few years. People with high-risk of cardiovascular diseases usually include adults with hypertension, diabetes, obesity, and other factors.
Adults segment is estimated to touch around USD 150,000 thousand in 2020. Moreover, the increasing geriatric population across the world is expected to raise demand for wearable cardioverter defibrillator to monitor and manage cardiovascular diseases. Among pediatric patients, congenital heart disease is the most common heart defect. Although cardiovascular disorders are a great concern in adult population, the increasing prevalence of childhood obesity has increased the risk of cardiovascular complications in children, which in turn is anticipated to drive the growth of the wearable cardioverter defibrillators market.
Companies Mentioned
- ZOLL Medical Corporation
- Element Science Inc.
- Medtronic plc
- Kestra Medical Technologies Inc.
- Abbott
- Boston Scientific Corporation
- LivaNova plc
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- General Electric Company.
Key Topics Covered:
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview
2. Assumptions And Acronyms
3. Research Methodology
4. Analyst Review
5. Executive Summary - Global Wearable Cardioverter Defibrillator Market
6. Regulatory & Standards Landscape
7. Analysis Of Market Dynamics
7.1. Growth Drivers
7.2. Market Trends
8. Major Roadblocks For The Market Growth
9. Risk Analysis
10. Impact Of Covid-19 On The Wearable Cardioverter Defibrillator Market
11. Key Market Opportunities
12. Epidemiology Analysis
13. Analysis Of Wearable Cardioverter Defibrillator Manufacturers
14. Assessment Of End Users Of Wearable Cardioverter Defibrillator
15. Growth Opportunity Analysis For Business Development
16. Analysis On The Wearable Cardioverter Defibrillator Ecosystem
17. Competitive Structure
- Competitive Benchmarking
- Detailed Overview
- Assessment Of Key Product Offerings
- Analysis Of Growth Strategies
- Exhaustive Analysis On Key Financial Indicators
- Swot Analysis
- Market Share Analysis Of Leading Companies In Wearable Cardioverter Defibrillator Market
- Company Assessment For Players Operating In The Market
- Zoll Medical Corporation
- Company Assessment For Players With Product In Pipeline
- Kestra Medical Technologies, Inc.
- Element Science
- Medtronic
- General Electric
18. Global Wearable Cardioverter Defibrillator Market Outlook
- By Value (USD Million)
- Global Wearable Cardioverter Defibrillator Market Segmentation Analysis, 2019-2028
- By Indication
- Peripartum Cardiomyopathy, 2019-2028f (USD Thousand)
- Congenital Heart Disease, 2019-2028f (USD Thousand)
- Ventricular Arrhythmias, 2019-2028f (USD Thousand)
- Tetralogy Or Fallot, 2019-2028f (USD Thousand)
- Myocardial Infarction, 2019-2028f (USD Thousand)
- Wolff-Parkinson White Syndrome, 2019-2028f (USD Thousand)
- Others, 2019-2028f (USD Thousand)
- By Demography
- Pediatric, 2019-2028f (USD Thousand)
- Adults, 2019-2028f (USD Thousand)
- Geriatric, 2019-2028f (USD Thousand)
- By End User
- Hospitals, 2019-2028f (USD Thousand)
- Home Care Settings, 2019-2028f (USD Thousand)
- Cardiology Clinics, 2019-2028f (USD Thousand)
- By Region
- Asia Pacific, 2019-2028f (USD Thousand)
- North America, 2019-2028f (USD Thousand)
- Latin America, 2019-2028f (USD Thousand)
- Europe, 2019-2028f (USD Thousand)
- Middle East & Africa, 2019-2028f (USD Thousand)
19. North America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
20. Europe Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
21. Asia Pacific Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
22. Latin America Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
23. Middle East & Africa Wearable Cardioverter Defibrillator Market Outlook, 2019-2028
For more information about this report visit https://www.researchandmarkets.com/r/2gu40z
